logo
Select company
Select metric
$ -320KNet Cash Flow - Investing
VS
Market
69
Sector
47
Industry
33
History
33
$ 2.24Close
$ 1.52 - $ 4.53 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -320K
3/31/2025$ -319K
12/31/2024$ -699K
6/30/2024$ -1.28M
12/31/2023$ -419K
6/30/2023$ 817.5K
12/31/2022$ 1.87M
6/30/2022$ 690K
12/31/2021$ -526.25K
6/30/2021$ -266.25K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) CF - Investing stands at $ 1.87M.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average CF - Investing has been $ 128.75K.
  • The median CF - Investing for MEREO BIOPHARMA GROUP PLC during this period was $ -319K
  • MEREO BIOPHARMA GROUP PLC reached its highest CF - Investing over the past 5 years at $ 1.87M.
  • The lowest CF - Investing recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe $ -1.28M

MEREO BIOPHARMA GROUP PLC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
CRDF : CARDIFF ONCOLOGY INC $ -24.49MABEO : ABEONA THERAPEUTICS INC $ 172.81MHUMA : HUMACYTE INC $ -1.79MAVTX : AVALO THERAPEUTICS INC $ -70.86MCOYA : COYA THERAPEUTICS INC $ 0ABVC : ABVC BIOPHARMA INC $ -665.78KFDMT : 4D MOLECULAR THERAPEUTICS INC $ 52.46MVTGN : VISTAGEN THERAPEUTICS INC $ -8.47MERNA : ERNEXA THERAPEUTICS INC $ -19KANNX : ANNEXON INC $ 125.79M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

MREO - Net Cash Flow - Investing, Last 5 years

$ -1.28M

Minimum

Jun 30, 2024

$ 1.87M

Maximum

Dec 31, 2022

$ 128.75K

Average

$ -319K

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.26M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.26M
median$ -6.38M
std$ 83.34M